Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro

Lupus

Volumn 8, Issue 6, 1999, Pages 423-429

  Del Papa, N ^a   Raschi, E ^a   Moroni, G ^a   Panzeri, P ^a   Borghi, M O ^a   Ponticelli, C ^a   Tincani, A ^b   Balestrieri, G ^b   Meroni, P L ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SPEDALI CIVILI   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Adhesion molecules; Anti endothelial cell antibodies; Cytokines; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CELL ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANTIGEN BINDING; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; MONOLAYER CULTURE; PHENOTYPE; PRIORITY JOURNAL; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS; UMBILICAL VEIN; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0032879792     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339900800603     Document Type: Article

References (39)

1. Cines DB, Lyss AP, Reeber M et al. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984; 73: 611-625.
2. Le Roux G, Wautier MP, Guillevin L, Wautier JL. IgG binding to endothelial cells in systemic lupus erythematosus. Thromb Haemost 1986; 56: 144-146.
3. Hashemi S, Smith CD, Izaguite CA. Antiendothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J Lab Clin Med. 1987: 109: 434-440.
4. Rosenbaum J, Pottinger BE, Woo P et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol. 1988; 72: 450-456.
5. Vismara A, Meroni PL, Tincani A et al. Antiphospholipid antibodies and endothelial cells. Clin Exp Immunol 1988; 74: 247-253.
6. Brasile L, Kremer JM, Clarke JL, Cerilli J. Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med 1989; 87: 74-80.
7. Quadros NP, Roberts-Thompson PJ, Gallus AS. IgG and IgM antiendothelial cell antibodies in patients with collagen-vascular disorders. Rheum Int 1990; 10: 113-119.
8. D'Cruz DP, Houssiau FA, Ramirez G et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol. 1991; 85: 254-261.
9. Perry GJ, Elston T, Khouri NA et al. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage. Quarterly J Med 1993; 86: 727-734.
10. Del Papa N, Conforti G, Gambini D et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin. Immunol Immunopath 1994; 70: 211-216.
11. Meroni PL, D'Cruz D, Khamastha MA, Hughes GRV. Antiendothelial cell antibodies : for scientist or for clinicians too? Clin Exp Immunol 1996; 104: 199-202.
12. Chan EM, Chenk IHP. Prospective study of antiendothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopath 1996; 78: 41-46.
13. Navarro M, Cervera R, Font J et al. Antiendothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997; 6: 521-526.
14. Van der Zee, Siegert CEH, De Vreede TA et al. Characterization of anti-endothelial antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol. 1991; 84: 238-244.
15. Li JS, Liu MF, Lei HY. Characterization of antiendothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity. Clin Immunol Immunopath 1996; 79: 211-216.
16. Chan TM, Yu PM, Tsang KLC, Cheng IKP. Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clin Exp Immunol 1995; 100: 506-513.
17. Hill MB, Phipps JL, Milford-Ward A et al. Further characterization of antiendothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996; 35: 1231-1238.
18. Del Papa N, Guidali L, Spatola L et al. Relationship between anti-phospholipid and anti-endothelial antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13: 179-186.
19. Penning CA, French MA, Rowell NR, Hughes PJ. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J Clin Lab Immunol 1985; 17: 125-130.
20. Del Papa N, Guidali L, Sala A et al. Endothelial cell as target for antiphospholipid antibodies. Arthritis Rheum 1997; 40: 551-561.
21. Del Papa N, Guidali L, Sironi M et al. Antiendothelial IgG antibodies from Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-766.
22. Carvalho D, Savage COS, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 1996; 97: 111-119.
23. Levy Y, Gilburd B, George J et al. Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA. Intern Immunol 1998; 10: 861-868.
24. Tan EN, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
25. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
26. Whiteside TL, Dixon JA. Clinical usefulness of the Crithidia lucilae test for antibodies to native DNA. Am J Clin Pathol 1979; 72: 829-835.
27. Ter Borg EJ, Horst G, Hummel EJ et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term prospective study. Arthritis Rheum 1990; 33: 634-643.
28. Tincani A, Meroni PL, Brucato A et al. Antiphospholipid and antimitochondrial type M5 antibodies in SLE. Clin Exp Rheumatol 1985; 3 321-326.
29. Balestrieri G, Tincani A, Spatola L et al. Anti-β2 glycoprotein I antibodies: a marker of anti-phospholipid syndrome. Lupus 1995; 4: 122-130.
30. Del Papa N, Raschi E, Catelli L et al. Endothelial cells as a target for antiphospholipid antibodies: role of anti-β2-glycoprotein I antibodies. Am J Reproduct Immunol 1997; 38: 212-217.
31. Kapahi P, Mason JC, Lebranchu Y et al. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993; 92: 412-418.
32. Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 3: 376-383.
33. Carson CW, Beall LD, Hunder GG et al. Serum E-selectin is increased in vasculitis, scleroderema, and systemic lupus erythematosus. J Rheumatol 1993; 20: 809-814.
34. Gearing AJH, Hemingway I, Pigott R et al. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-I and VCAM-I: pathological significance. Ann N Y Acad Sci 1992; 667: 324-331.
35. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994; 84: 2068-2101.
36. Linker-Israeli M, Deans RJ, Wallace DJ et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117-123.
37. Sponk PE, ter Borg EJ, Limburg PC, Kallenberg CGM. Plasma concentrations of IL-6 in systemic lupus erythematosus: an indicator of disease activity? Clin Exp Immunol 1992; 90: 106-110.
38. Crisp SJ, Dunn MJ, Rose ML et al. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transpl 1994; 13: 81-91.
39. Dunn MJ, Crisp SJ, Rose ML et al. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566-1570.